Cancer: Biomimetic Tissue-Engineered Technologies

Deadline
Multiple
OPPORTUNITY NO.
PAR-16-105
MECHANISM
U01
RESEARCH AREA(S)
SYNOPSIS

This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology. The projects supported by this FOA will establish and collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program.

The Cancer TEC Program will (1) catalyze the advancement of innovative, well characterized in vitro and ex vivo systems available for cancer research, (2) expand the breadth of these systems to several cancer types, and (3) promote the exploration of cancer phenomena with biomimetic tissue-engineered systems.

Deadlines:
• Pre-Application Submission Deadline: 6 weeks before application submission due date
• Application Submission Deadline: 5:00 PM local time of applicant organization, May 30, 2017; Nov. 30, 2017; May 30, 2018; Nov. 30, 2018

ELIGIBILITY

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.